COS Cardio

https://coscardio.ie/direct-echo-service-for-gps/

New Direct Echo Service for GPs - Cos Cardio Direct Access Echocardiograhy Now AvailableThis service allows you to refer patients directly for an echocardiogram, without the need for a prior consultation with a cardiologist.

https://cplhealthcare.com/job/clinical-nurse-specialist-cardiology-role/

Clinical Nurse Specialist Cardiology Role | Cpl Healthcare Position Available: Clinical Nurse Specialist (Cardiology) About the Practice: Operating out of the Cork Clinic, Western Road and Bon Secours Hospital, Cork, COS Cardio, is dedicated to delivering exceptional cardiovascular care. With a focus on advanced diagnostic testing, multimodality cardiovascu...

Thanks to PCRonline for selecting the Hydra 🐍 case for publication.

Taming of the Hydra – percutaneous coronary intervention of a single coronary artery arising from the right sinus of Valsalva | PCRonline A single coronary artery arising from the right sinus of Valsalva with absent left main stem is an extremely rare coronary artery anomaly. Herein, a case of percutaneous coronary intervention (PCI) to a high grade proximal left anterior descending (LAD) stenosis of an anomalous single coronary arter...

Bon Secours Cork - Official Healthcare Partner of Cork City FC! 🤝

📰 - https://www.corkcityfc.ie/home/2021/04/28/bon-secours-cork-official-healthcare-partner-of-ccfc/

We Have Moved Premises - Cos Cardio We Have Moved Premises We have moved premises Due to the expansion of our cardiovascular services and the increasing number of patient referrals, we have moved to a larger premises. As of January 1st 2021, our new address and telephone number are as follows: Suite 21 Clinic B The Cork Clinic Western...

Metabolic Disease: Is It the Fat, Sugar, or Processed Food? As rates of obesity and type 2 diabetes rise, we have yet to identify the culprit of metabolic disease. Dr Caroline Apovian reviews and comments on a debate at this year's ADA meeting.

Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study BACKGROUND: It is unclear whether seasonal changes, school closures or other public health interventions will result in a slowdown of the current coronavirus disease 2019 (COVID-19) pandemic. We aimed to determine whether epidemic growth is globally associated with climate or public health intervent...

This device for stroke prevention (Amplatzer Amulet from Abbott) has been available for patients in the Bon Secours Hospital, Cork for over a year now. It is now undergoing a large randomized controlled trial in the United States.

Today, we announced that the FDA has approved a first-of-its-kind trial that could lead to a new therapy option for people at risk of stroke, who have previously been limited to a lifetime of blood thinner medication. Our global, multicenter CATALYST trial will compare the effectiveness of Abbott’s Amplatzer Amulet device, which is currently investigational in the U.S., to modern versions of anticoagulants (NOACs) in lowering the risk of stroke for people with atrial fibrillation, a condition with a projected prevalence rate of 12.1 million by 2030 in the U.S. alone. With the results of the trial, we’re hoping to change clinical practice by eliminating this lifetime need for blood thinners for these patients.

Low-Fat, Low-Carb Diets Equally Beneficial if Healthy Foods Included Neither low-fat nor low-carbohydrate diets on their own increased the risk of death, however, unhealthy food choices in each make a small difference.

First in Ireland RotaPro™ cases performed in the Bon Secours Hospital, Cork On November 29th 2019, the cardiology team in Bon Secours Hospital, Cork became the first centre in Ireland to use the new rotational atherectomy system known as RotaPro™. The device is manufactured by Boston Scientific in the Cork facility, which employs 890 people.

Healthy Lifestyle Adds Up to a Decade More of Disease-Free Life Following a healthy lifestyle could increase life expectancy free of cancer, CVD, and diabetes by up to 10 years in people in their middle years, suggests a large US analysis.